AKARX
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.
AKARX
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2005-01-01
Address:
Paramus, New Jersey, United States
Country:
United States
Status:
Active
Total Funding:
21.1 M USD
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Atterx Biotherapeutics
Atterx develops therapeutics to fight the growing epidemic of antibiotic resistant bacteria.
Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.
Investors List
Sutter Hill Ventures
Sutter Hill Ventures investment in Series A - AkaRx
InterWest Partners
InterWest Partners investment in Series A - AkaRx
InterWest Partners
InterWest Partners investment in Series A - AkaRx
Sutter Hill Ventures
Sutter Hill Ventures investment in Series A - AkaRx
InterWest Partners
InterWest Partners investment in Series A - AkaRx
Sutter Hill Ventures
Sutter Hill Ventures investment in Series A - AkaRx
More informations about "AkaRx"
AkaRx 2025 Company Profile: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for AkaRx. Use the PitchBook Platform to explore the full profile.See details»
AkaRx - Crunchbase Company Profile & Funding
AkaRx develops therapeutics including the orally-available small molecule for …See details»
AkaRx - 2025 Company Profile & Team - Tracxn
Jun 23, 2025 Explore AkaRx's in-depth company profile, including funding details, key investors, leadership, and competitors.See details»
AkaRx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore AkaRx, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 2 literature, Disease Domain:Neoplasms, Immune System ...See details»
AkaRx - Products, Competitors, Financials, Employees, …
United Biomedical is a biopharmaceutical organization that develops diagnostics and immunotherapeutics for health conditions. The company develops vaccines, proteins, …See details»
Akarx Inc · 240 Leigh Farm Rd, Ste 245, Durham, NC 27707-8100
AKARX INC is an entity in Durham, North Carolina registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The entity was registered …See details»
Organization | AkaRx
AkaRx Report issue Contributed to NMEFor profit Founded: Paramus NJ United States (2004) Status: Acquired by Eisai (2010) → now Sarepta Therapeutics (2014) Organization Overview …See details»
AkaRx - Ownership and Business Overview | Mergr
AkaRx Business Overview Where is AkaRx headquartered? AkaRx is headquartered in Paramus, New Jersey. What sector is AkaRx in? AkaRx is a life science company. When was AkaRx …See details»
AKARX, INC. - New York Company
AKARX, INC. (DOS ID: 6523145) was incorporated on 06/28/2022 in New York. Their business is recorded as FOREIGN BUSINESS CORPORATION. The Company's current operating status …See details»
AkaRx Inc/NC - Company Profile and News - Bloomberg Markets
Company profile page for AkaRx Inc/NC including stock price, company news, executives, board members, and contact informationSee details»
Eisai Completes Acquisition of AkaRx, Inc. in the United States
Jan 7, 2010 With the completion of the acquisition, AkaRx has become a wholly-owned subsidiary of Eisai Inc. while Eisai has obtained the exclusive worldwide rights to develop, …See details»
Akarx, Inc. - Company Profile - Corporation Wiki
Apr 6, 2022 View company leaders and background information for Akarx, Inc. Search our database of over 100 million company and executive profiles.See details»
AkaRx, Inc. · 3015 Carrington Mill Boulevard, Suite 410, Morrisville ...
AkaRx, Inc. (Entity # 20221595379) is a FPC in Morrisville, North Carolina registered with the Colorado Department of State (CDOS). The entity was formed on June 20, 2022 in the …See details»
AkaRx, Inc - VentureRadar
AkaRx, Inc VentureRadar profile. Find out more about AkaRx, Inc including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Akarx, Inc. Albany, NY - filing information
Jun 28, 2022 Akarx, Inc. is a Albany, NY based company incorporated on June 28, 2022. Filing details extracted from the New York Department of State's Division of Corporations as of …See details»
AkaRx, Inc.:Company Profile & Technical Research,Competitor …
AkaRx, Inc. is a company that provides Avatrombopag, Pharmacy and Therapeutics, Hematology and more. AkaRx, Inc. is headquartered in United States New Jersey. AkaRx, Inc. was …See details»
AkaRx Inc - Company Profile and News - Bloomberg Markets
Dec 1, 2004 Company profile page for AkaRx Inc including stock price, company news, executives, board members, and contact informationSee details»
AkaRx - Funding, Financials, Valuation & Investors - Crunchbase
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.See details»
AkaRx, Inc. - VentureRadar
Epizyme USA Listed Epizyme, Inc. is a fully integrated, commercial-stage biopharmaceutical company committed to its mission of rewriting treatment for cancer and other serious diseases …See details»
AkaRx | VentureRadar
AkaRx VentureRadar profile. Find out more about AkaRx including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»